Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dýrarannsóknir - lipid breytandi lyf - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - blóðrauði, ofsakláði - Ónæmisbælandi lyf - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
kolsuspension mixtúra, dreifa 150 mg/ml
circius pharma ab - carbo medicinalis - mixtúra, dreifa - 150 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
trimetoprim meda mixtúra, dreifa 10 mg/ml
viatris aps - trimethoprimum inn - mixtúra, dreifa - 10 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
decutan mjúkt hylki 10 mg
teva b.v.* - isotretinoinum inn - mjúkt hylki - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
decutan mjúkt hylki 20 mg
teva b.v.* - isotretinoinum inn - mjúkt hylki - 20 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
lederspan stungulyf, dreifa 20 mg/ml
viatris aps - triamcinolonum hexacetóníð - stungulyf, dreifa - 20 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol mixtúra, dreifa 20 mg/ml
novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
túfen saft 13,33 mg/ml
laboratoria qualiphar - guaifenesinum inn - saft - 13,33 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zovirax (zovir) mixtúra, dreifa 80 mg/ml
glaxosmithkline pharma a/s - aciclovirum inn - mixtúra, dreifa - 80 mg/ml